Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLosing 100 pounds on Wegovy takes most people roughly 18 to 36 months, depending on starting weight, the dose reached, lifestyle changes and individual biology. That wide range is honest rather than evasive — clinical trial data show average body-weight reductions of around 15% over 68 weeks at the 2.4 mg maintenance dose, and your starting weight determines how many pounds that 15% actually represents. Wegovy (semaglutide) is a prescription-only medicine; a prescriber assesses whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial (1,961 adults with obesity, no diabetes, followed for 68 weeks) found that participants on semaglutide 2.4 mg lost an average of around 15% of their body weight compared with roughly 2.4% on placebo, as published in the New England Journal of Medicine. At a starting weight of 230 lb (about 104 kg), a 15% reduction is roughly 34 lb. To lose 100 lb from that starting point, you would need to reach and sustain a higher percentage loss over a longer period than the trial measured.
That is not a ceiling — it is a snapshot. The trial ended at 68 weeks; real-world treatment continues. Participants who lost the most weight tended to start heavier, sustain the full maintenance dose, and maintain consistent dietary changes alongside the medicine. The newer 7.2 mg dose, approved by the MHRA in January 2026, reported average losses of around 20.7% over 72 weeks in supporting trials, narrowing the gap with tirzepatide and suggesting greater potential for people who tolerate and need the higher dose.
If you want to understand how the early weeks typically unfold before significant loss becomes visible, the first signs of weight loss on Wegovy is worth reading alongside this page.
This is the question most calculators skip. A 15% reduction means very different things depending on where you start. Someone at 350 lb loses 52.5 lb at 15%, still a long way from 100. Someone at 500 lb loses 75 lb at the same percentage. To reach 100 lb of total loss, a heavier starting weight shortens the timeline considerably, all else being equal, simply because each percentage point is worth more in absolute pounds.
Equally, body composition shifts as you lose weight. Resting metabolic rate falls when you weigh less, which is one reason loss tends to slow over time. This is not a Wegovy-specific problem; it is how human physiology works. The medicine helps by reducing appetite and slowing gastric emptying, but it does not override the body's long-term adaptive responses entirely. Our overview of weight-loss timelines on Wegovy covers the biological factors that shape pace more broadly.
It is worth being honest here: we know some readers arrive at this page carrying a specific number in their head, a goal that has probably been there for years. That kind of ambition deserves a straight answer rather than vague reassurance, which is why the numbers above are real ones from real trials, not estimates designed to impress.
Several things act as accelerators or brakes on the pace of loss. Dose is among the most significant, the titration schedule starts at 0.25 mg and climbs over roughly 16 weeks; people who tolerate the increases without prolonged GI side effects tend to reach effective doses sooner. How long Wegovy takes to work goes into the dose-response relationship in more detail.
Diet quality remains important even though appetite falls markedly. Protein adequacy, staying hydrated and keeping fibre intake consistent all help preserve lean tissue during rapid loss. Physical activity, particularly resistance work, matters for the same reason. None of this requires perfection, but the NHS notes that medicines like Wegovy are most effective alongside a reduced-calorie diet and increased activity, which is also what the licensed indication requires. You can find the NHS position on weight-management medicines on NHS England's weight-management injections guidance.
Sleep, stress and any underlying metabolic conditions (thyroid function, for instance) also influence the rate of loss, and a prescriber reviewing your progress is better placed than any general guide to identify what might be slowing things down. If you are considering how the broader process of treatment is structured, our weight-loss treatment overview sets out what to expect from start to finish.
For people starting at a high enough weight, yes, 100 lb of loss is within the range supported by clinical data, particularly at the 7.2 mg dose and over a treatment period beyond the 68–72 weeks most trials measured. It requires sustained treatment, clinical re-review at each repeat, and the lifestyle work running alongside.
The practical check is simpler than most people expect: clinicians typically look for at least 5% weight loss after six months at the maintenance dose. If that has not happened, continuing on the same dose is usually reviewed. If it has, there is a solid foundation to build on. The question of how long treatment should continue is one a prescriber answers based on your individual progress, not a fixed rule.
If you are thinking about what a 40-pound milestone might look like on the way to a larger goal, our page on losing 40 pounds with Wegovy gives a grounded intermediate reference point. For those weighing up the metric equivalent, our 10 kg timeline guide may also help frame early progress.
Wegovy is a prescription-only medicine; suitability is assessed by a qualified prescriber before any treatment starts. If you would like that clinical conversation, speak to our prescribers through a free consultation and get a same-day review from a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.